GlassScriptPhysician profile
Eve M Burns
NPI 1548407562
$824.42
in general payments reported to CMS, 2019-2025
9 companies · $472 in 2025
The $472 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $91.37 · 2020: $83.86 · 2021: $113 · 2022: $50.12 · 2023: $13.72 · 2025: $472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $391 · Food and Beverage: $94.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $390.93 |
| Food and Beverage | $94.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $471.96 | 2025 | |
| Abbvie INC. | $124.50 | 2019-2021 | |
| Amgen INC. | $68.83 | 2019-2022 | |
| Roche Diagnostics Corporation | $42.30 | 2019 | |
| Meditrina | $32.09 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $28.43 | 2019-2021 | |
| Novo Nordisk INC | $23.45 | 2020 | |
| Myovant Sciences INC. | $19.14 | 2021 | |
| Hologic Sales and Service, LLC | $13.72 | 2023 | Omni Hysteroscope, Acessa Provu System, Myosure Tissue Removal Device |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eve Burns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.